| Diabetes Care and Treatment Project: A Joslin Telemedicine Initiative |
OCT 2006 |
55 pages |
| Authors:
Sven-Erik Bursell; JOSLIN DIABETES CENTER BOSTON MA
|
 | Most of the proposed studies have cleared local and HSRRB approvals and are in various stages of implementation at participating sites. Those that have yet to be approved are through the planning phase. For completed studies, results have been analyzed and manuscripts are being prepared for submission to academic conferences and peer reviewed journals. The JVN application has been integrated to include both eye care and diabetes care in readiness ... |
|
| New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes |
NOV 2005 |
5 pages |
| Authors:
Robert A. Vigersky; CHILDREN'S HOSPITAL OF PITTSBURGH PA
|
| The hypothesis to be tested is that there are allelic variations of some genes that make the development of diabetesrelated complications more likely in patients who carry them than those who do not. The 3 major complications to be evaluated are diabetic nephropathy, diabetic neuropathy, and diabetic retinopathy. This is an observational study in which the investigators will obtain DNA samples from the blood of patients with one or more ... |
|
| New Advanced Technology to Improve Prediction and Prevention of Type 1 Diabetes |
NOV 2003 |
463 pages |
| Authors:
Massimo Trucco; CHILDREN'S HOSPITAL OF PITTSBURGH PA
|
| Type 1 diabetes is considered an auto immune disease characterized by the presence of inflammatory cells in the islets of Langerhas. These cells are T lymphocytes, considered responsible for the destruction of the insulin producing beta-cells present in the islets. When the majority of the beta cells are dead, the disease presents, frequently with an abrupt and clinically serious onset. Individuals are considered at high risk to develop the disease, ... |
|
| Proceedings of the Workshop on Implementation of Screening and Eye Examinations for Diabetic Retinopathy held in Bethesda, MD on 27-28 February 2001 |
AUG 2001 |
45 pages |
| Authors:
Robert A. Goldstein; JUVENILE DIABETES FOUNDATION INTERNATIONAL NEW YORK NY
|
| Diabetic retinopathy is the leading cause of blindness in working-age adults today. Fortunately, 90% of this vision loss is preventable with early screening and treatment. Because the number of people with diabetes is expected to double in the next 30 years, it is vital that effective strategies are implemented now to improve retinopathy screening rates. In an effort to confront this problem head on and address the challenges of promoting ... |
|
Reports by Keyword(s)
RETINOPATHY
